Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06974097
What this trial is testing

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

Who this might be right for
Non-Small Cell Lung Cancer
University Hospital, Montpellier 72
Early research (Phase 1)Not Yet RecruitingNCT07581574
What this trial is testing

Neoadjuvant SHR-A1811 and SHR-A1701 for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 12
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Testing effectiveness (Phase 2)Looking for participantsNCT06770270
What this trial is testing

Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)

Who this might be right for
Rectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 68
Not applicableLooking for participantsNCT04286841
What this trial is testing

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Who this might be right for
ImmunotherapyLung Cancer
Guangdong Association of Clinical Trials 100
Testing effectiveness (Phase 2)Ended earlyNCT05908786
What this trial is testing

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07254858
What this trial is testing

Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer

Who this might be right for
HR+/HER2- Breast Cancer
First Affiliated Hospital of Wenzhou Medical University 302
Testing effectiveness (Phase 2)Looking for participantsNCT06353685
What this trial is testing

De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.

Who this might be right for
De-escalated Radiotherapy; Head and Neck Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 103
Not applicableNot Yet RecruitingNCT07067450
What this trial is testing

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sichuan University 98
Post-approval studies (Phase 4)Not Yet RecruitingNCT06311916
What this trial is testing

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

Who this might be right for
HCC
Chen Xiaoping 312
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07617818
What this trial is testing

QL1706 Combined With Cisplatin/Paclitaxel as Neoadjuvant Therapy for Cervical Cancer

Who this might be right for
Cervical CancerNeoadjuvant TherapyImmunotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06814158
What this trial is testing

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Who this might be right for
Esophageal Squamour Cell Cancer
Tianjin Medical University Cancer Institute and Hospital 57
Not applicableLooking for participantsNCT07401199
What this trial is testing

Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

Who this might be right for
Gastric Cancer (GC)Locally Advanced Gastric Cancer
Qun Zhao 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT06987734
What this trial is testing

Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 25
Not applicableLooking for participantsNCT06623487
What this trial is testing

The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungPET / CTNeoadjuvant Immunotherapy
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06718309
What this trial is testing

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
First People's Hospital of Hangzhou 40
Not applicableLooking for participantsNCT07627347
What this trial is testing

Efficacy and Safety of Anlotinib Combined With Bemocizumab for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma(ESCC)

Who this might be right for
ESCC
Nanfang Hospital, Southern Medical University 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07596290
What this trial is testing

Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC

Who this might be right for
Locally Advanced Rectal AdenocarcinomaNeoadjuvant ChemoradiationNeoadjuvant Immunotherapy
Beijing Friendship Hospital 342
Large-scale testing (Phase 3)Looking for participantsNCT04973306
What this trial is testing

Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Stage IIEsophageal Squamous Cell Carcinoma Stage III
Shanghai Zhongshan Hospital 176
Not applicableUnknownNCT05137912
What this trial is testing

Neoadjuvant Immunotherapy in Advanced NSCLC

Who this might be right for
Lung Cancer, Non-small Cell
Power Life Sciences Inc. 10
Next Page